Clinical relevance of Luminex donor-specific crossmatches: Data from 165 renal transplants

Tissue Antigens

Volumn 74, Issue 3, 2009, Pages 205-212

  Billen, E V A ^a   Christiaans, M H L ^a   Van Den Berg Loonen, E M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibodies; Donor specific crossmatch; Human leucocyte antigen class I and II; Kidney transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MICROSPHERES; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 68249131779     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01283.x     Document Type: Article

References (27)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969 : 280 : 735 9.
2. Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003 : 3 : 1488 500.
3. Christiaans M, Overhof R, Haaft ten A, Nieman F, Hooff van JP, Berg van den-Loonen EM. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 1996 : 62 : 1341 7.
4. Pei R, Lee J-H, Shih N-J, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003 : 75 : 43 9.
5. El-Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005 : 66 : 989 97.
6. Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 2008 : 86 : 384 90.
7. Billen EVA, Voorter CEM, Christiaans MHL, Berg van den-Loonen EM. Luminex donor-specific crossmatches. Tissue Antigens 2008 : 71 : 507 13.
8. Scornik JC, Brunson ME, Schaub B, Howard RJ, Pfaff WW. The crossmatch in renal transplantation. Transplantation 1994 : 57 : 621 5.
9. Bray RA. Flow cytometry crossmatching for solid organ transplantation. Methods Cell Biol 1994 : 41 : 103 19.
10. Ta M, Scornik JC. Improved flow cytometric detection of donor-specific HLA class II antibodies by heat inactivation. Transplantation 2002 : 73 : 1611 4.
11. Cook DJ, Terasaki PI, Iwaki Y, Terashita GY, Lau M. An approach to reducing early kidney transplant failure by flow cytometry crossmatching. Clin Transplant 1987 : 1 : 253 6.
12. Mahoney RJ, Ault KA, Given SR et al. The flow cytometric crossmatch and early renal transplant loss. Transplantation 1990 : 49 : 527 35.
13. Scornik JC, Clapp W, Patton PR et al. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive. Transplantation 2001 : 71 : 1098 102.
14. Süsal C, Opelz G. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Hum Immunol 2004 : 65 : 810 6.
15. Karpinski M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicty crossmatch. J Am Soc Nephrol 2001 : 12 : 2807 14.
16. Ogura K, Terasaki PI, Johnson C et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation 1993 : 56 : 294 8.
17. Ishida H, Tanabe K, Furusawa M et al. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation. Transpl Int 2005 : 18 : 163 8.
18. Bielmann D, Hönger G, Lutz D, Mihatsch MJ, Steiger J, Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007 : 7 : 626 32.
19. Patel AM, Pancoska C, Mulgaonkar S, Weng FL. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007 : 7 : 2371 7.
20. Lefaucheur C, Suberbielle-Boissel C, Hill GS et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008 : 8 : 324 31.
21. Berg van den-Loonen EM, Billen EVA, Voorter CEM et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008 : 85 : 1086 90.
22. Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? Transplantation 2008 : 85 : 1200 4.
23. Bas le-Bernardet S, Hourmant M, Valentin N et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003 : 75 : 477 82.
24. Eng HS, Bennett G, Tsiopelas E et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008 : 8 : 2335 42.
25. Pollinger HS, Stegali MD, Gloor JM et al. Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 2007 : 7 : 857 63.
26. Issa N, Cosio FG, Gloor JM et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008 : 86 : 681 5.
27. Duquesnoy RJ. Human leukocyte antigen class II antibodies and transplant outcome. Transplantation 2008 : 86 : 638 40.